Progesterone and Estrogen Regulate Alzheimer-Like Neuropathology in Female 3xTg-AD Mice

Estrogen depletion in postmenopausal women is a significant risk factor for the development of Alzheimer's disease (AD), and estrogen-based hormone therapy may reduce this risk. However, the effects of progesterone both alone and in combination with estrogen on AD neuropathology remain unknown. In this study, we used the triple transgenic mouse model of AD (3xTg-AD) to investigate the individual and combined effects of estrogen and progesterone on β-amyloid (Aβ) accumulation, tau hyperphosphorylation, and hippocampal-dependent behavioral impairments. In gonadally intact female 3xTg-AD mice, AD-like neuropathology was apparent by 3 months of age and progressively increased through age 12 months, a time course that was paralleled by behavioral impairment. Ovariectomy-induced depletion of sex steroid hormones in adult female 3xTg-AD mice significantly increased Aβ accumulation and worsened memory performance. Treatment of ovariectomized 3xTg-AD mice with estrogen, but not progesterone, prevented these effects. When estrogen and progesterone were administered in combination, progesterone blocked the beneficial effect of estrogen on Aβ accumulation but not on behavioral performance. Interestingly, progesterone significantly reduced tau hyperphosphorylation when administered both alone and in combination with estrogen. These results demonstrate that estrogen and progesterone independently and interactively regulate AD-like neuropathology and suggest that an optimized hormone therapy may be useful in reducing the risk of AD in postmenopausal women.

[1]  L. Garcia-Segura,et al.  Effects of progesterone and its reduced metabolites, dihydroprogesterone and tetrahydroprogesterone, on the expression and phosphorylation of glycogen synthase kinase‐3 and the microtubule‐associated protein Tau in the rat cerebellum , 2007, Developmental neurobiology.

[2]  J. D. McGaugh,et al.  Learning Decreases Aβ*56 and Tau Pathology and Ameliorates Behavioral Decline in 3xTg-AD Mice , 2007, The Journal of Neuroscience.

[3]  M. Schumacher,et al.  Progesterone treatment of spinal cord injury , 2007, Journal of Molecular Neuroscience.

[4]  F. LaFerla,et al.  Reduction of Soluble Aβ and Tau, but Not Soluble Aβ Alone, Ameliorates Cognitive Decline in Transgenic Mice with Plaques and Tangles* , 2006, Journal of Biological Chemistry.

[5]  Frank M LaFerla,et al.  Androgens Regulate the Development of Neuropathology in a Triple Transgenic Mouse Model of Alzheimer's Disease , 2006, The Journal of Neuroscience.

[6]  C. Pike,et al.  Progestins inhibit the neuroprotective effects of estrogen in rat hippocampus , 2006, Brain Research.

[7]  K. Francis,et al.  Progesterone reverses the spatial memory enhancements initiated by tonic and cyclic oestrogen therapy in middle‐aged ovariectomized female rats , 2006, The European journal of neuroscience.

[8]  W. Klein,et al.  Temporal Profile of Amyloid-β (Aβ) Oligomerization in an in Vivo Model of Alzheimer Disease , 2006, Journal of Biological Chemistry.

[9]  C. Behl,et al.  Glycogen synthase kinase 3β links neuroprotection by 17β-estradiol to key Alzheimer processes , 2005, Neuroscience.

[10]  Rena Li,et al.  Brain estrogen deficiency accelerates Abeta plaque formation in an Alzheimer's disease animal model. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[11]  M. Rowan,et al.  The role of cell-derived oligomers of Abeta in Alzheimer's disease and avenues for therapeutic intervention. , 2005, Biochemical Society transactions.

[12]  S. Paul,et al.  Estrogen therapy fails to alter amyloid deposition in the PDAPP model of Alzheimer's disease. , 2005, Endocrinology.

[13]  J. Ávila,et al.  Estradiol Prevents Neural Tau Hyperphosphorylation Characteristic of Alzheimer's Disease , 2005, Annals of the New York Academy of Sciences.

[14]  P. Maki,et al.  A Systematic Review of Clinical Trials of Hormone Therapy on Cognitive Function: Effects of Age at Initiation and Progestin Use , 2005, Annals of the New York Academy of Sciences.

[15]  D. Murphy,et al.  The Women's Health Initiative Memory Study: findings and implications for treatment , 2005, The Lancet Neurology.

[16]  C. Behl,et al.  Glycogen synthase kinase 3beta links neuroprotection by 17beta-estradiol to key Alzheimer processes. , 2005, Neuroscience.

[17]  A. Granholm,et al.  Progesterone counteracts estrogen-induced increases in neurotrophins in the aged female rat brain , 2004, Neuroreport.

[18]  P. Hurn,et al.  Effects of Combined Estrogen and Progesterone on Brain Infarction in Reproductively Senescent Female Rats , 2004, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[19]  M. Rosenfeld,et al.  Norgestimate and medroxyprogesterone acetate do not attenuate the atheroprotective effects of 17beta-estradiol in ovariectomized, apolipoprotein E-deficient mice. , 2004, Fertility and sterility.

[20]  L. Schneider.  Estrogen and dementia: insights from the Women's Health Initiative Memory Study. , 2004, JAMA.

[21]  JoAnn E Manson,et al.  Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study. , 2004, JAMA.

[22]  H. Tanila,et al.  Estrogen treatment improves spatial learning in APP + PS1 mice but does not affect beta amyloid accumulation and plaque formation , 2004, Experimental Neurology.

[23]  R. Brinton.  Impact of Estrogen Therapy on Alzheimer’s Disease , 2004, CNS drugs.

[24]  F. LaFerla,et al.  Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer’s disease , 2003, Neurobiology of Aging.

[25]  D. Dickson,et al.  Co-localization of glycogen synthase kinase-3 with neurofibrillary tangles and granulovacuolar degeneration in transgenic mice. , 2003, The American journal of pathology.

[26]  M. Mattson,et al.  Triple-Transgenic Model of Alzheimer's Disease with Plaques and Tangles Intracellular Aβ and Synaptic Dysfunction , 2003, Neuron.

[27]  G. Fiskum,et al.  Ovarian steroid modulation of seizure severity and hippocampal cell death after kainic acid treatment , 2003, Experimental Neurology.

[28]  J. Manson,et al.  Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. , 2003, JAMA.

[29]  Robert B Wallace,et al.  Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. , 2003, JAMA.

[30]  Brenda L Plassman,et al.  Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache County Study. , 2002, JAMA.

[31]  J. Hardy,et al.  The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics , 2009 .

[32]  T. van Groen,et al.  Low Levels of Estrogen Significantly Diminish Axonal Sprouting after Entorhinal Cortex Lesions in the Mouse , 2002, The Journal of Neuroscience.

[33]  G. Arendash,et al.  Behavioral characterization of the Tg2576 transgenic model of Alzheimer's disease through 19 months , 2002, Physiology & Behavior.

[34]  Brian J Cummings,et al.  Optimization of techniques for the maximal detection and quantification of Alzheimer’s-related neuropathology with digital imaging , 2002, Neurobiology of Aging.

[35]  J. Lafrancois,et al.  Modulation of Aβ peptides by estrogen in mouse models , 2002, Journal of neurochemistry.

[36]  J. Simpkins,et al.  Modulation of A(beta) peptides by estrogen in mouse models. , 2002, Journal of neurochemistry.

[37]  Jonathan D. Smith,et al.  17α-estradiol and 17β-estradiol treatments are effective in lowering cerebral amyloid-β levels in AβPPSWE transgenic mice , 2002 .

[38]  Jonathan D. Smith,et al.  17Alpha-estradiol and 17beta-estradiol treatments are effective in lowering cerebral amyloid-beta levels in AbetaPPSWE transgenic mice. , 2002, Journal of Alzheimer's disease : JAD.

[39]  W. Mack,et al.  Comparison of estrogen and androgen levels after oral estrogen replacement therapy. , 2001, The Journal of reproductive medicine.

[40]  R. Traystman,et al.  LY353381.HCl, a Selective Estrogen Receptor Modulator, and Experimental Stroke , 2000, Stroke.

[41]  R. Gibbs.  Effects of gonadal hormone replacement on measures of basal forebrain cholinergic function , 2000, Neuroscience.

[42]  J. Jolles,et al.  The nature of the effect of female gonadal hormone replacement therapy on cognitive function in post-menopausal women: a meta-analysis , 2000, Neuroscience.

[43]  S. Gandy,et al.  Ovariectomy and 17β-estradiol modulate the levels of Alzheimer’s amyloid β peptides in brain , 2000, Neurology.

[44]  S. Gandy,et al.  Ovariectomy and 17beta-estradiol modulate the levels of Alzheimer's amyloid beta peptides in brain. , 2000, Neurology.

[45]  S. Gandy,et al.  Ovariectomy and 17beta-estradiol modulate the levels of Alzheimer's amyloid beta peptides in brain. , 2000, Experimental gerontology.

[46]  R. Traystman,et al.  Neuroprotective effects of female gonadal steroids in reproductively senescent female rats. , 2000, Stroke.

[47]  C. Pike,et al.  Estrogen modulates neuronal Bcl-xL expression and beta-amyloid-induced apoptosis: relevance to Alzheimer's disease. , 2001, Journal of neurochemistry.

[48]  L. Garcia-Segura,et al.  Gonadal hormones affect neuronal vulnerability to excitotoxin-induced degeneration , 1999, Journal of neurocytology.

[49]  George Paxinos,et al.  The Mouse Brain in Stereotaxic Coordinates , 2001 .

[50]  R. Brookmeyer,et al.  A prospective study of estrogen replacement therapy and the risk of developing Alzheimer''s disease , 1997 .

[51]  V. Henderson,et al.  Estrogen replacement therapy and risk of Alzheimer disease. , 1996, Archives of internal medicine.

[52]  Yaakov Stern,et al.  Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease , 1996, The Lancet.

[53]  E. Vanmechelen,et al.  Monoclonal antibody AT8 recognises tau protein phosphorylated at both serine 202 and threonine 205 , 1995, Neuroscience Letters.

[54]  D. Pomp,et al.  Rescue of pregnancy and maintenance of corpora lutea in infertile transgenic mice expressing an ovine metallothionein 1a-ovine growth hormone fusion gene. , 1995, Biology of reproduction.

[55]  D. Stein,et al.  Progesterone Facilitates Cognitive Recovery and Reduces Secondary Neuronal Loss Caused by Cortical Contusion Injury in Male Rats , 1994, Experimental Neurology.

[56]  V. Henderson,et al.  Estrogen deficiency and risk of Alzheimer's disease in women. , 1994, American journal of epidemiology.

[57]  H. Gundersen,et al.  Unbiased stereological estimation of the total number of neurons in the subdivisions of the rat hippocampus using the optical fractionator , 1991, The Anatomical record.